Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Oncoimmunology|February 1, 2014
Role of non-classical MHC class I molecules in cancer immunosuppressionGrazyna Kochan, David Escors, Karine Breckpot, et al.
Pathology International|June 26, 2012
Pleomorphic carcinoma of the breast with expression of macrophage markers: report of two casesAlicia Córdoba, Maria Del Rosario Mercado, Francisco Vicente, et al.
Histopathology|September 4, 2013
Differential gene hypermethylation in genital lichen sclerosus and cancer: a comparative studyDavid Guerrero-Setas, Noemí Pérez-Janices, Amaya Ojer, et al.
Cancers|December 10, 2021
A Novel Prognostic Biomarker Panel for Early-Stage Colon CarcinomaPablo Azcue, David Guerrero Setas, Ignacio Encío, et al.
International Journal of Surgical Pathology|May 1, 2024
Primary Cutaneous Acral CD8-Positive Lymphoproliferative Disorder: A Case Report With Nonacral PresentationAlejandro Pasco Peña, Luiz Miguel Nova-Camacho, Irene Fernandez, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 13, 2019
Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoringMarta Barrado, Idoia Blanco-Luquin, Paola Andrea Navarrete, et al.
Cancers|April 30, 2021
PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype ClassificationPablo Azcue, Ignacio Encío, David Guerrero Setas, et al.
Biomedicines|October 23, 2021
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer DiagnosisSaioa Mendaza, David Guerrero-Setas, Iñaki Monreal-Santesteban, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2013
RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancerDavid Guerrero-Setas, Noemí Pérez-Janices, Laura Blanco-Fernandez, et al.
International Journal of Molecular Sciences|February 6, 2020
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast CancerSaioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal-Santesteban, et al.
Pageof 3